Brief: MGC Pharmaceuticals Says £1.2 Mln Raised In Conditional Placing
11/04/2023 07:45
April 11 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MGC PHARMACEUTICALS - £1.2 MILLION RAISED IN A
CONDITIONAL
PLACING
* MGC PHARMACEUTICALS LTD - CANNEPIL PHASE 2B CLINICAL TRIAL
FUNDING SECURED UP TO C.£0.63 MILLION
* MGC PHARMACEUTICALS LTD - UK BROKER OPTION SHARE OFFER TO
RAISE
UP TO £0.75 MILLION
Source text for Eikon: ID:nRSK7819Va
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group